Aakalu Girish N 4
4 · GENOCEA BIOSCIENCES, INC. · Filed Mar 17, 2022
Insider Transaction Report
Form 4
Aakalu Girish N
CHIEF BUSINESS OFFICER
Transactions
- Award
Common Stock
2022-03-15+31,250→ 77,819 total - Sale
Common Stock
2022-03-16$1.10/sh−2,397$2,637→ 75,422 total - Award
Stock Option (Right to Buy)
2022-03-15+93,750→ 93,750 totalExercise: $1.11Exp: 2032-03-15→ Common Stock (93,750 underlying)
Footnotes (3)
- [F1]Restricted stock units that represent the contingent right to receive, at settlement, one share of common stock. The restricted stock units are scheduled to vest 25% on each of the first four anniversaries of the grant date.
- [F2]Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.
- [F3]The options are scheduled to vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.